Your browser doesn't support javascript.
loading
The Distinctive Features behind the Aggressiveness of Oral and Cutaneous Squamous Cell Carcinomas.
Alonso-Juarranz, Miguel; Mascaraque, Marta; Carrasco, Elisa; Gracia-Cazaña, Tamara; De La Sen, Oscar; Gilaberte, Yolanda; Gonzalez, Salvador; Juarranz, Ángeles; Falahat, Farzin.
Affiliation
  • Alonso-Juarranz M; Oral and Maxillofacial Surgery Service, Hospital Clínico San Carlos, 28040 Madrid, Spain.
  • Mascaraque M; Surgery Department, Faculty of Medicine, Universidad Complutense, 28040 Madrid, Spain.
  • Carrasco E; Department of Biology, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
  • Gracia-Cazaña T; Translational Research Unit, Miguel Servet University Hospital, Instituto Investigación Sanitaria Aragón (IIS), 50009 Zaragoza, Spain.
  • De La Sen O; Department of Biology, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
  • Gilaberte Y; Department of Experimental Dermatology and Skin Biology, Instituto Ramón y Cajal de Investigación Sanitaria, IRYCIS, 28034 Madrid, Spain.
  • Gonzalez S; Department of Dermatology, Miguel Servet University Hospital, Instituto Investigación Sanitaria Aragón (IIS), 50009 Zaragoza, Spain.
  • Juarranz Á; Oral and Maxillofacial Surgery Service, Hospital Clínico San Carlos, 28040 Madrid, Spain.
  • Falahat F; Surgery Department, Faculty of Medicine, Universidad Complutense, 28040 Madrid, Spain.
Cancers (Basel) ; 15(12)2023 Jun 17.
Article de En | MEDLINE | ID: mdl-37370836
ABSTRACT
Squamous cell carcinomas arise from stratified squamous epithelia. Here, a comparative analysis based on recent studies defining the genetic alterations and composition of the stroma of oral and cutaneous squamous cell carcinomas (OSCC and CSCC, respectively) was performed. Both carcinomas share some but not all histological and genetic features. This review was focused on how mutations in tumor suppressor genes and protooncogenes cooperate to determine the differentiation, aggressiveness, and metastatic potential of OSCC and CSCC. In fact, driver mutations in tumor suppressor genes are more frequently observed in OSCC than CSCC. These include mutations in TP53 (encoding pP53 protein), CDKN2A (encoding cyclin dependent kinase inhibitor 2A), FAT1 (encoding FAT atypical cadherin 1), and KMT2D (encoding lysine methyltransferase 2D), with the exception of NOTCH (encoding Notch receptor 1), whose mutation frequency is lower in OSCC compared to CSCC. Finally, we describe the differential composition of the tumor microenvironment and how this influences the aggressiveness of each tumor type. Although both OSCC and CSCC tumors are highly infiltrated by immune cells, high levels of tumor-infiltrating lymphocytes (TILs) have been more frequently reported as predictors of better outcomes in OSCC than CSCC. In conclusion, OSCC and CSCC partially share genetic alterations and possess different causal factors triggering their development. The tumor microenvironment plays a key role determining the outcome of the disease.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Cancers (Basel) Année: 2023 Type de document: Article Pays d'affiliation: Espagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Cancers (Basel) Année: 2023 Type de document: Article Pays d'affiliation: Espagne